Search Results

Press Releases

CereVasc Announces First Enrollment in STRIDE Clinical Trial of the eShunt® System for Normal Pressure Hydrocephalus

January 14, 2025

·

3 min read

Press Releases

CereVasc to Present at the Piper Sandler 36th Annual Healthcare Conference

November 25, 2024

·

1 min read

Genetown

CereVasc Receives FDA IDE Approval for the STRIDE Pivotal Study of the eShunt System for Treatment of Normal Pressure Hydrocephalus

CereVasc, Inc. announced today that it has received approval from the US Food and Drug Administration (FDA) to initiate its “Pivotal Study to Evaluate the Safety and Effectiveness of the CereVasc® eShunt® System in the Treatment of Normal Pressure Hydrocephalus” (STRIDE trial).

May 7, 2024

·

2 min read

Genetown

CereVasc Announces $70 Million Series B Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus

CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced it has successfully completed the initial closing of a $70 Million Series B financing.

May 13, 2024

·

2 min read

Press Releases

CereVasc Announces Appointments of New Directors

July 16, 2024

·

3 min read

Genetown

CereVasc’s eShunt® System Study Data Presented at the ABC WIN Seminar

CereVasc, Inc. announced that data from its clinical studies in the United States and Argentina, examining the use of its eShunt System to treat communicating hydrocephalus, was presented at the ABC WIN Seminar in Val d’Isere.

January 23, 2024

·

2 min read

Press Releases

CereVasc Announces Enrollment of the 50th Patient in Pilot Studies of the eShunt® System for Normal Pressure Hydrocephalus

September 17, 2024

·

2 min read

Press Releases

CereVasc Announces Journal of Molecular Therapy Publication Highlighting the eShunt® Platform as a CNS Gene Therapy Delivery Method

September 26, 2024

·

4 min read

Genetown

CereVasc’s eShunt™ System to be Presented at the International Stroke Conference by Dr. Pedro Lylyk

CereVasc, Inc. announced that Dr. Pedro Lylyk, Director General of ENERI, will deliver a symposium presentation entitled, “Endovascular Shunting for Hydrocephalus After Subarachnoid Hemorrhage and Other Applications,” at the International Stroke Conference in Phoenix, Arizona on Wednesday, February 7th.

February 7, 2024

·

2 min read

Business

CereVasc & LianMedical Announce Corporate Partnership

CereVasc, Inc. and LianMedical announced a partnership focused on bringing CereVasc’s eShunt® System and related products to patients and providers in China, Hong Kong, Taiwan, and Macaw.

June 26, 2023

·

2 min read